Alzheimer's Event: Amyloid PET Imaging and Dementia at UCSF
Date
Learn what you need to know for your Medicare patients with memory complaints, and how amyloid PET imaging could help your Medicare patients at our complimentary dinner and symposium. Register here
Please contact us if you cannot attend this event, but would like to learn more about this topic.
SNMMI (Society of Nuclear Medicine and Molecular Imaging) Complimentary Dinner Symposium with 2 CME credits
"Amyloid PET Imaging and Dementia: What you Need to Know for Your Medicare Patients with Memory Complaints"
Tuesday, July 19, 2016
6:00-8:30 pm
Mission Bay Conference Center
1675 Owens Street
San Francisco, CA
Parking onsite
AGENDA
| 6:00-6:20 pm | Reception and Buffet Opens |
| 6:20-6:30 pm |
Welcome and Opening Remarks Miguel Pampaloni, MD, PhD Elizabeth Edgerly, PhD |
| 6:30-7:00 pm | Advances in Diagnosis and Treatment, Michael Weiner, MD |
| 7:00-7:30 pm | Imaging for Dementia Care, Miguel Pampaloni, MD, PhD |
| 7:30-8:00 pm | Helping Dementia Patients Through Clinical Trials: National IDEAS Trial, Gil Rabinovici, MD |
| 8:00-8:30 pm | Panel Discussion |
BACKGROUND INFORMATION
Lapses in memory and confused thinking could be normal signs of getting older, or they could suggest something more serious, such as Alzheimer's disease.
We are proud to be a site for the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study. This $100 million study will be the largest of its kind, eventually enrolling over 18,000 patients. The study was developed by the IDEAS study group, which included Gil Rabinovici, MD, of the UCSF Department of Neurology; Maria Carrillo, PhD, chief science officer of the Alzheimer's Association, and other partners. The IDEAS Study is led by the Alzheimer's Association and the American College of Radiology Imaging Network (ACRIN) and managed by the American College of Radiology (ACR).
741 America/Los_Angeles publicType
Time Duration
Location
Learn what you need to know for your Medicare patients with memory complaints, and how amyloid PET imaging could help your Medicare patients at our complimentary dinner and symposium. Register here
Please contact us if you cannot attend this event, but would like to learn more about this topic.
SNMMI (Society of Nuclear Medicine and Molecular Imaging) Complimentary Dinner Symposium with 2 CME credits
"Amyloid PET Imaging and Dementia: What you Need to Know for Your Medicare Patients with Memory Complaints"
Tuesday, July 19, 2016
6:00-8:30 pm
Mission Bay Conference Center
1675 Owens Street
San Francisco, CA
Parking onsite
AGENDA
| 6:00-6:20 pm | Reception and Buffet Opens |
| 6:20-6:30 pm |
Welcome and Opening Remarks Miguel Pampaloni, MD, PhD Elizabeth Edgerly, PhD |
| 6:30-7:00 pm | Advances in Diagnosis and Treatment, Michael Weiner, MD |
| 7:00-7:30 pm | Imaging for Dementia Care, Miguel Pampaloni, MD, PhD |
| 7:30-8:00 pm | Helping Dementia Patients Through Clinical Trials: National IDEAS Trial, Gil Rabinovici, MD |
| 8:00-8:30 pm | Panel Discussion |
BACKGROUND INFORMATION
Lapses in memory and confused thinking could be normal signs of getting older, or they could suggest something more serious, such as Alzheimer's disease.
We are proud to be a site for the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study. This $100 million study will be the largest of its kind, eventually enrolling over 18,000 patients. The study was developed by the IDEAS study group, which included Gil Rabinovici, MD, of the UCSF Department of Neurology; Maria Carrillo, PhD, chief science officer of the Alzheimer's Association, and other partners. The IDEAS Study is led by the Alzheimer's Association and the American College of Radiology Imaging Network (ACRIN) and managed by the American College of Radiology (ACR).
Speakers
Department of Radiology and Biomedical Imaging
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco